J&J launches Shockwave C2 Aero catheter for calcified CAD treatment

J&J has globally launched its Shockwave C2 Aero coronary IVL catheter, which aims to help in the treatment of calcified CAD. The Shockwave C2 Aero is designed to streamline treatment strategies by improving flexibility for physicians. CAD is characterised by a progressive accumulation of cholesterol in blood vessels. Credit: Orawan Pattarawimonchai / Shutterstock.com. Johnson & Johnson (J&J) has globally launched its Shockwave C2 Aero coronary IVL catheter, developed to improve deliverability, lesion crossing, and repositioning for the treatment of calcified coronary artery disease (CAD). This next-generation device builds on the established mechanism and safety record of previous Shockwave IVL catheters…

Source: Medical Device Network